These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study. Russo V; Caturano A; Guerra F; Migliore F; Mascia G; Rossi A; Nesti M; Santobuono VE; Attena E; Tola G; Sciarra L; Conte G; Paoletti Perini A; Francia P; Dendramis G; Palamà Z; Albani S; Ottonelli Ghidini A; Calò L; D'Onofrio A; Baldi E; Heart Vessels; 2023 May; 38(5):680-688. PubMed ID: 36418560 [TBL] [Abstract][Full Text] [Related]
33. Profile of patients with Brugada syndrome presenting with their first documented arrhythmic event: Data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS). Milman A; Andorin A; Gourraud JB; Postema PG; Sacher F; Mabo P; Kim SH; Juang JJM; Maeda S; Takahashi Y; Kamakura T; Aiba T; Conte G; Sarquella-Brugada G; Leshem E; Rahkovich M; Hochstadt A; Mizusawa Y; Arbelo E; Huang Z; Denjoy I; Giustetto C; Wijeyeratne YD; Napolitano C; Michowitz Y; Brugada R; Casado-Arroyo R; Champagne J; Calo L; Tfelt-Hansen J; Priori SG; Takagi M; Veltmann C; Delise P; Corrado D; Behr ER; Gaita F; Yan GX; Brugada J; Leenhardt A; Wilde AAM; Brugada P; Kusano KF; Hirao K; Nam GB; Probst V; Belhassen B Heart Rhythm; 2018 May; 15(5):716-724. PubMed ID: 29325976 [TBL] [Abstract][Full Text] [Related]
34. Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome. De Maria E; Cappelli S; Cappato R Heart Rhythm; 2013 Dec; 10(12):1807-9. PubMed ID: 23933298 [No Abstract] [Full Text] [Related]
35. Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern. Rossi A; Giannoni A; Nesti M; Notarstefano P; Castiglione V; Solarino G; Teresi L; Mirizzi G; Russo V; Panchetti L; Startari U; Ripoli A; Gentile F; Santoro A; Botto N; Casolo G; Sieira J; Pieroni M; Santangeli P; Emdin M; Piacenti M Europace; 2023 Feb; 25(2):651-659. PubMed ID: 36196034 [TBL] [Abstract][Full Text] [Related]
36. A phenotypic combination of idiopathic VF and Brugada syndrome. Martinek M; Purerfellner H Pacing Clin Electrophysiol; 2010 Sep; 33(9):e84-7. PubMed ID: 20230473 [TBL] [Abstract][Full Text] [Related]
37. Role of endocardial ablation in eliminating an epicardial arrhythmogenic substrate in patients with Brugada syndrome. Kamakura T; Cochet H; Juhoor M; Nakatani Y; Ramirez FD; André C; Nakashima T; Krisai P; Takagi T; Tixier R; Chauvel R; Cheniti G; Duchateau J; Pambrun T; Derval N; Kusano K; Sacher F; Jaïs P; Haïssaguerre M; Hocini M Heart Rhythm; 2021 Oct; 18(10):1673-1681. PubMed ID: 34182174 [TBL] [Abstract][Full Text] [Related]
38. [Long-term outcome after cardioverter-defibrillator implantation in patients with Brugada syndrome]. Binbin Y; Jingping L; Bing Y; Minglong C; Jiangang Z; Kejiang C; Qijun S Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Aug; 43(8):690-4. PubMed ID: 26955725 [TBL] [Abstract][Full Text] [Related]
39. Catheter ablation in highly symptomatic Brugada patients: a Dutch case series. Haanschoten DM; Elvan A; Postema PG; Smit JJJ; Adiyaman A; Ter Bekke RMA; Asaad N; Aanhaanen WTJ; Misier ARR; Delnoy PPHM; Crijns HJGM; Wilde AAM Clin Res Cardiol; 2020 May; 109(5):560-569. PubMed ID: 31478073 [TBL] [Abstract][Full Text] [Related]
40. Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome. Gonzalez Corcia MC; Sieira J; Pappaert G; de Asmundis C; Chierchia GB; La Meir M; Sarkozy A; Brugada P J Am Coll Cardiol; 2018 Jan; 71(2):148-157. PubMed ID: 29325638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]